Journal of Medicinal Chemistry p. 4858 - 4865 (1992)
Update date:2022-07-30
Topics: Synthesis Molecular docking Inhibitor In vitro Testing Structure-Activity Relationship (SAR) Pharmacokinetics High-Throughput Screening (HTS) Heterocyclic compound Enzyme inhibition assay IC50 (Half-Maximal Inhibitory Concentration)
Singh, Baldev
Lesher, George Y.
Pluncket, Kevin C.
Pagani, Edward D.
Bode, Donald C.
et al.
Two series of medorinone (3) analogs were prepared by modifications at C(2) and C(5).The C(2)-series was prepared from 2-chloro-5-methyl-1,6-naphthyridine (4) by replacement of the chloro group with various nucleophiles.The C(5)-series was prepared from 5
View MoreContact:+86-(0)21-3770 9035
Address:Room 301, Building 2, Meijiabang Road 1508, Shanghai China
Suzhou Health Chemicals Co., Ltd.
website:http://www.healthchems.com
Contact:13776257979
Address:No. 338, Jingang Avenue,
Contact:+1 (647) 918 5848
Address:2343 BRIMLEY RD., Suite 250
KangZhiYuan Pharmaceutical Company Limited
Contact:(Sabrina)86-20-85273232
Address:4th floor, building B, Dadi industry zone, Tangxia, Tianhe, Guangzhou, China
Kaymossy BioChem Tech Co., Ltd
website:http://www.kaimosi.com
Contact:0571-87191913/0571-87199097
Address:Room 215, Building 3rd, No.288 Ningxia Road, Qingdao city, China
Doi:10.1002/ejoc.200800305
(2008)Doi:10.1021/acschembio.0c00757
(2021)Doi:10.1021/jo961982m
(1997)Doi:10.1016/S0040-4020(97)00644-3
(1997)Doi:10.1038/ja.2010.164
(2011)Doi:10.1016/0022-328X(85)80366-1
(1985)
